CCM
PPBT

Condor Capital Management’s Purple Biotech PPBT Stock Holding History

Condor Capital Management’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-105
Closed -$96K – 421
2021
Q3 		$96K Hold
105
– – 0.01% 207
2021
Q2 		$102K Buy
+105
New +$96.4K 0.01% 206

Other funds holding PPBT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WTB
Washington Trust Bank Spokane, Washington $1.36B AUM 21.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Condor Capital Management's PPBT Position: Q4 2021 in Review

Condor Capital Management sold out of Purple Biotech (PPBT) in Q4 2021, closing a stake of 105 shares — an estimated $96K sold.

Condor Capital Management first reported a position in PPBT in Q2 2021 and held it in 2 quarters. The position peaked at $102K in Q2 2021. 10 funds tracked by Wall St. Rank hold PPBT as of Q4 2021.

  • Condor Capital Management reported no remaining Purple Biotech position as of Q4 2021 after selling out during the quarter.
  • Condor Capital Management sold 105 Purple Biotech shares in Q4 2021, an estimated $96K.
  • Condor Capital Management first reported a position in Purple Biotech in Q2 2021 and held it in 2 quarters.
  • Condor Capital Management's Purple Biotech position peaked at $102K in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2021.

Based on Condor Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.